Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A25122 | 22154902 | Life Sci | Alpha-lipoic acid attenuates methionine choline deficient diet-induced steatohepatitis in C57BL/6 mice. | 2011 | Details |
| A25123 | 22154224 | Clin Res Hepatol Gastroenterol | Ursodeoxycholic acid with vitamin E in patients with nonalcoholic steatohepatitis: long-term results. | 2011 | Details |
| A25126 | 22152380 | Zhonghua Gan Zang Bing Za Zhi | [SREBP-1c knockdown attenuated fatty degeneration in hepatic L02 cells and inhibited CCL2 and FGF21 protein expression]. | 2011 | Details |
| A25127 | 22152379 | Zhonghua Gan Zang Bing Za Zhi | [Establishment and identification of non-alcoholic fatty liver disease in chronic hepatitis B virus infected mice]. | 2011 | Details |
| A25128 | 22152378 | Zhonghua Gan Zang Bing Za Zhi | [The role of Fas mutation on non-alcoholic steatohepatitis in mice]. | 2011 | Details |
| A25133 | 22152320 | Zhonghua Gan Zang Bing Za Zhi | [Effects of telmisartan on nonalcoholic steatohepatitis rat model by activating peroxisome proliferator-activated receptor r]. | 2011 | Details |
| A25134 | 22152305 | Cell Metab | Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease. | 2011 | Details |
| A25137 | 22149719 | Ann Med | Mapping body fat distribution: a key step towards the identification of the vulnerable patient? | 2011 | Details |
| A25139 | 22149546 | Diabetes Technol Ther | Inflammatory markers in relation to nonalcoholic fatty liver disease in urban South Indians. | 2011 | Details |
| A25140 | 22147010 | Endocrinology | Thyroid hormone receptor-α gene knockout mice are protected from diet-induced hepatic insulin resistance. | 2011 | Details |
| A25141 | 22143620 | Int J Obes (Lond) | Hepatic left lobe volume is a sensitive index of metabolic improvement in obese women after gastric banding. | 2011 | Details |
| A25142 | 22142284 | Clin Sci (Lond) | Bias in macrophage activation pattern influences non-alcoholic steatohepatitis (NASH) in mice. | 2012 | Details |
| A25143 | 22141340 | J Gastroenterol Hepatol | Genetic variation in PNPLA3 but not APOC3 influences liver fat in non-alcoholic fatty liver disease. | 2012 | Details |
| A25144 | 22140659 | Acta Biochim Pol | Cytokeratin-18 and hyaluronic acid levels predict liver fibrosis in children with non-alcoholic fatty liver disease. | 2011 | Details |
| A25145 | 22140316 | Vasc Health Risk Manag | Evaluation of carotid intima-media thickness and flow-mediated dilatation in middle-aged patients with nonalcoholic fatty liver disease. | 2011 | Details |
| A25146 | 22139492 | Nihon Shokakibyo Gakkai Zasshi | [A case of non-alcoholic fatty liver disease (NAFLD) aggravated after treatment with raloxifene]. | 2011 | Details |
| A25147 | 22138733 | Eur Radiol | Specificity of unenhanced CT for non-invasive diagnosis of hepatic steatosis: implications for the investigation of the natural history of incidental steatosis. | 2011 | Details |
| A25148 | 22136330 | Liver Int | Overexpression of 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue and portal hypercortisolism in non-alcoholic fatty liver disease. | 2011 | Details |
| A25149 | 22135029 | J Clin Pathol | Bile duct changes in different etiologic types of end-stage chronic liver disease: a study on native explant livers. | 2011 | Details |
| A25150 | 22134222 | Curr Opin Gastroenterol | Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression. | 2012 | Details |
| A25151 | 22133576 | Clin Res Hepatol Gastroenterol | Influence of non-alcoholic fatty liver disease on the prognosis in patients with colorectal cancer. | 2011 | Details |
| A25152 | 22132342 | J Lipids | Ezetimibe: its novel effects on the prevention and the treatment of cholesterol gallstones and nonalcoholic Fatty liver disease. | 2011 | Details |
| A25153 | 22132232 | PLoS One | Synergy analysis reveals association between insulin signaling and desmoplakin expression in palmitate treated HepG2 cells. | 2011 | Details |
| A25154 | 22129796 | Gastroenterol Nurs | Predictors of nonalcoholic steatohepatitis in obese children. | 2012 | Details |
| A25155 | 22129639 | J Nutr Biochem | The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease. | 2011 | Details |
| A25156 | 22126450 | Scand J Gastroenterol | Low clinical relevance of the nonalcoholic fatty liver disease activity score (NAS) in predicting fibrosis progression. | 2011 | Details |
| A25157 | 22126026 | Adv Clin Chem | Iron overload in nonalcoholic steatohepatitis. | 2011 | Details |
| A25159 | 22125617 | PLoS One | Coordinated defects in hepatic long chain fatty acid metabolism and triglyceride accumulation contribute to insulin resistance in non-human primates. | 2011 | Details |
| A25160 | 22124850 | Curr Gastroenterol Rep | Iron metabolism in Nonalcoholic Fatty Liver Disease. | 2012 | Details |
| A25161 | 22122481 | Curr Pharm Biotechnol | Non-alcoholic steatohepatitis: new insights from OMICS studies. | 2012 | Details |
| A25162 | 22121808 | Zhongguo Zhong Yao Za Zhi | [Effect of total alkaloids of Rubus alceaefolius on oxidative stress in rats with non-alcoholic fatty liver disease]. | 2011 | Details |
| A25163 | 24843533 | J Diabetes Investig | Impact of glucose tolerance on the severity of non-alcoholic steatohepatitis. | 2011 | Details |
| A25164 | 22120683 | J Ethnopharmacol | Lipid regulation effects of Polygoni Multiflori Radix, its processed products and its major substances on steatosis human liver cell line L02. | 2011 | Details |
| A25165 | 22120206 | J Hepatol | Obesity, inflammation, and liver cancer. | 2011 | Details |
| A25166 | 22119618 | Dig Liver Dis | N-glycan based biomarker distinguishing non-alcoholic steatohepatitis from steatosis independently of fibrosis. | 2011 | Details |
| A25167 | 22119555 | Eur J Radiol | Acoustic radiation force impulse-imaging and transient elastography for non-invasive assessment of liver fibrosis and steatosis in NAFLD. | 2011 | Details |
| A25168 | 22118966 | Mol Cell Endocrinol | Adiponectin upregulates hepatocyte CMKLR1 which is reduced in human fatty liver. | 2011 | Details |
| A25169 | 22118645 | Int J Exp Pathol | Pathology of the liver in obese and diabetic ob/ob and db/db mice fed a standard or high-calorie diet. | 2011 | Details |
| A25170 | 22117531 | Aliment Pharmacol Ther | Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease. | 2011 | Details |
| A25171 | 22115060 | BMC Res Notes | Non-alcoholic fatty liver disease in a rural, physically active, low income population in Sri Lanka. | 2011 | Details |
| A25172 | 22114515 | Int J Gen Med | Evaluation of atherosclerotic findings in patients with nonalcoholic fatty liver disease. | 2011 | Details |
| A25173 | 22112382 | Drug Metab Dispos | Molecular mechanism of altered ezetimibe disposition in nonalcoholic steatohepatitis. | 2011 | Details |
| A25174 | 22112193 | Metab Syndr Relat Disord | Association of serum lipoprotein-associated phospholipase A2 level with nonalcoholic fatty liver disease. | 2011 | Details |
| A25175 | 22111971 | Aliment Pharmacol Ther | Non-alcoholic fatty liver disease is associated with low bone mineral density in obese children. | 2011 | Details |
| A25176 | 22111040 | Diabetes Metab J | Dietary oleate has beneficial effects on every step of non-alcoholic Fatty liver disease progression in a methionine- and choline-deficient diet-fed animal model. | 2011 | Details |
| A25177 | 22110479 | Exp Diabetes Res | Inhibition of aldose reductase activates hepatic peroxisome proliferator-activated receptor-α and ameliorates hepatosteatosis in diabetic db/db mice. | 2011 | Details |
| A25178 | 22110478 | Exp Diabetes Res | Role of transcription factor modifications in the pathogenesis of insulin resistance. | 2011 | Details |
| A25179 | 22110476 | Exp Diabetes Res | Diagnosis and evaluation of nonalcoholic fatty liver disease. | 2011 | Details |
| A25180 | 22110273 | World J Gastroenterol | Non-alcoholic fatty liver disease and metabolic syndrome in obese children. | 2011 | Details |
| A25181 | 22110265 | World J Gastroenterol | Physical activity and nutrition attitudes in obese Hispanic children with non-alcoholic steatohepatitis. | 2011 | Details |
| A25182 | 22110053 | Gut | Genetic determinants of alcoholic liver disease. | 2011 | Details |
| A25183 | 22108808 | Obes Surg | Effect of bariatric surgery on liver fibrosis. | 2012 | Details |
| A25184 | 22108588 | Exp Cell Res | A methionine-choline-deficient diet elicits NASH in the immunodeficient mouse featuring a model for hepatic cell transplantation. | 2011 | Details |
| A25185 | 22108448 | Am J Gastroenterol | Ultrasonographically detected non-alcoholic fatty liver disease is an independent predictor for identifying patients with insulin resistance in non-obese, non-diabetic middle-aged Asian adults. | 2011 | Details |
| A25186 | 22108148 | J Clin Lipidol | 3-hydroxyl-3-methylglutaryl coenzyme A reductase inhibitor use in chronic liver disease: a therapeutic controversy. | 2011 | Details |
| A25187 | 22106162 | Orv Hetil | [Role of autophagy in the pathogenesis of liver diseases]. | 2011 | Details |
| A25188 | 22105730 | Minerva Gastroenterol Dietol | Nonalcoholic fatty liver disease: the concept and confusion. | 2011 | Details |
| A25189 | 22105311 | Eur J Nutr | Cardioprotective and hepatoprotective effects of ellagitannins from European oak bark (Quercus petraea L.) extract in rats. | 2011 | Details |
| A25190 | 22105182 | J Clin Gastroenterol | Coronary artery stents and antiplatelet therapy in patients with cirrhosis. | 2012 | Details |
| A25191 | 22103753 | Pharm Biol | Fish oil improves lipid metabolism and ameliorates inflammation in patients with metabolic syndrome: impact of nonalcoholic fatty liver disease. | 2011 | Details |
| A25192 | 22103042 | Acta Gastroenterol Belg | Lean non-alcoholic fatty liver disease (Lean-NAFLD): a major cause of cryptogenic liver disease. | 2011 | Details |
| A25194 | 22102439 | BMJ | Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study. | 2011 | Details |
| A25196 | 22098947 | Liver Int | Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease. | 2011 | Details |
| A25197 | 22098614 | Liver Int | Growth hormone, dehydroepiandrosterone and adiponectin levels in non-alcoholic steatohepatitis: an endocrine signature for advanced fibrosis in obese patients. | 2011 | Details |
| A25198 | 22098270 | Liver Int | Impaired renal function in morbid obese patients with nonalcoholic fatty liver disease. | 2011 | Details |
| A25199 | 22098164 | J Gastroenterol Hepatol | Inflammatory stress exacerbates hepatic cholesterol accumulation via disrupting cellular cholesterol export. | 2012 | Details |
| A25200 | 22097893 | Liver Int | Neutrophil to lymphocyte ratio: a new marker for predicting steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease. | 2011 | Details |
| A25201 | 22097889 | J Gastroenterol Hepatol | Association of tumor necrosis factor-α gene promoter polymorphism at sites -308 and -238 with non-alcoholic fatty liver disease: a meta-analysis. | 2012 | Details |
| A25202 | 22097199 | Zhongguo Zhong Xi Yi Jie He Za Zhi | [Study on the distribution and characteristics of Chinese medicine syndrome in patients with nonalcoholic fatty liver disease]. | 2011 | Details |
| A25203 | 22096112 | Eur J Endocrinol | Recent advances in cardiovascular aspects of polycystic ovary syndrome. | 2011 | Details |
| A25204 | 22095799 | Hepatology | Hepatic ratio of phosphatidylcholine to phosphatidylethanolamine predicts survival after partial hepatectomy in mice. | 2012 | Details |
| A25205 | 22095588 | Hepatology | Glucokinase links Krüppel-like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver disease. | 2012 | Details |
| A25206 | 22094893 | Curr Top Microbiol Immunol | Contribution of the intestinal microbiota to human health: from birth to 100 years of age. | 2013 | Details |
| A25207 | 22093857 | Pediatr Clin North Am | Advances in pediatric nonalcoholic fatty liver disease. | 2011 | Details |
| A25208 | 22093607 | Gastroenterol Hepatol | Genetic factors associated with the presence and progression of nonalcoholic fatty liver disease: a narrative review. | 2011 | Details |
| A25209 | 22093454 | Liver Int | Prevention of free fatty acid-induced hepatic lipotoxicity by carnitine via reversal of mitochondrial dysfunction. | 2011 | Details |
| A25212 | 22093324 | Liver Int | Antioxidants as therapeutic agents for liver disease. | 2011 | Details |
| A25213 | 22087354 | World J Diabetes | A defect in the activities of Δ and Δ desaturases and pro-resolution bioactive lipids in the pathobiology of non-alcoholic fatty liver disease. | 2011 | Details |
| A25215 | 22087177 | Hepat Mon | Non-alcoholic fatty liver disease and correlation of serum alanin aminotransferase level with histopathologic findings. | 2011 | Details |
| A25217 | 22087137 | Hepat Mon | HCC, diet and metabolic factors: Diet and HCC. | 2011 | Details |
| A25218 | 22087126 | Hepat Mon | Noninvasive assessment of liver fibrosis with the aspartate transaminase to platelet ratio index (APRI): Usefulness in patients with chronic liver disease: APRI in chronic liver disease. | 2011 | Details |
| A25219 | 22087124 | Hepat Mon | Rosuvastatin reduces nonalcoholic fatty liver disease in patients with chronic hepatitis C treated with α-interferon and ribavirin: Rosuvastatin reduces NAFLD in HCV patients. | 2011 | Details |
| A25220 | 22083307 | Mol Cells | Time-dependent changes in lipid metabolism in mice with methionine choline deficiency-induced fatty liver disease. | 2011 | Details |
| A25221 | 22082482 | Curr Mol Med | The emerging role of endocrine disruptors in pathogenesis of insulin resistance: a concept implicating nonalcoholic fatty liver disease. | 2012 | Details |
| A25222 | 22082335 | Chem Res Toxicol | Glutathione-deficient mice are susceptible to TCDD-Induced hepatocellular toxicity but resistant to steatosis. | 2011 | Details |
| A25223 | 22082204 | Diabetol Metab Syndr | L-carnitine ameliorated fatty liver in high-calorie diet/STZ-induced type 2 diabetic mice by improving mitochondrial function. | 2011 | Details |
| A25224 | 22081919 | HPB (Oxford) | Metabolic syndrome and hepatic resection: improving outcome. | 2011 | Details |
| A25225 | 22081873 | Comp Hepatol | The effect of cocoa supplementation on hepatic steatosis, reactive oxygen species and LFABP in a rat model of NASH. | 2011 | Details |
| A25226 | 22081615 | J Am Coll Nutr | Metabolic syndrome in childhood from impaired carbohydrate metabolism to nonalcoholic fatty liver disease. | 2011 | Details |
| A25227 | 22077984 | Clin Endocrinol (Oxf) | Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels. | 2012 | Details |
| A25228 | 22076166 | Int J Clin Exp Pathol | Increased expression of zinc finger protein 267 in non-alcoholic fatty liver disease. | 2011 | Details |
| A25230 | 22074433 | Curr Pharm Des | Liver enzymes: potential cardiovascular risk markers? | 2011 | Details |
| A25231 | 22072850 | World J Gastroenterol | Decreased accumulation of ultrasound contrast in the liver of nonalcoholic steatohepatitis rat model. | 2011 | Details |
| A25232 | 22072427 | Metab Brain Dis | Contribution of hyperammonemia and inflammatory factors to cognitive impairment in minimal hepatic encephalopathy. | 2011 | Details |
| A25233 | 22067945 | Lipids Health Dis | Polyphenolic extract of lotus root (edible rhizome of Nelumbo nucifera) alleviates hepatic steatosis in obese diabetic db/db mice. | 2011 | Details |
| A25234 | 22067322 | Endocrinology | Prenatal dexamethasone exposure potentiates diet-induced hepatosteatosis and decreases plasma IGF-I in a sex-specific fashion. | 2011 | Details |
| A25235 | 22065161 | J Gastroenterol | Usefulness of differentiating metabolic syndrome into visceral fat type and subcutaneous fat type using ultrasonography in Japanese males. | 2011 | Details |
| A25236 | 22064361 | Free Radic Biol Med | Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. | 2011 | Details |
| A25237 | 22064320 | Lab Invest | A novel murine model for non-alcoholic steatohepatitis developed by combination of a high-fat diet and oxidized low-density lipoprotein. | 2011 | Details |
| A25238 | 22059955 | Health Technol Assess | Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review. | 2011 | Details |